Study Finds Increased Hospitalizations and Reduced Hospice Use in Patients Near End of Life Receiving Anti-Cancer Treatments
Research shows that cancer patients receiving aggressive treatments near death are hospitalized more often and less likely to access hospice care, impacting quality of life.
Recent research conducted by the University of Texas MD Anderson Cancer Center highlights a concerning trend in end-of-life cancer care. The study reveals that patients who undergo systemic anti-cancer therapies—such as chemotherapy, immunotherapy, or targeted treatments—closer to death are significantly more prone to hospitalization, intensive care admissions, and emergency department visits within the last 30 days of life. Conversely, these patients are less likely to access hospice services, which are essential for providing comfort and support in terminal stages.
The analysis, which utilized data from over 315,000 older adults with various cancers from the SEER Medicare database (2015-2020), showed that receiving cancer treatment near the end of life increases the likelihood of emergency room visits by threefold, hospital stays by 2.6 times, and ICU admissions by 1.8 times. Additionally, there is a higher chance of dying in the hospital and a lower probability of utilizing hospice care.
This pattern was consistent across different types of systemic therapies, emphasizing a broad issue in current end-of-life care practices. Dr. Kerin Adelson, chief quality and value officer at MD Anderson, commented that the overuse of aggressive cancer treatments late in life can cause significant harm. It often results in a more medicalized death—marked by unnecessary interventions, hospital stays, and out-of-home death locations—detracting from quality of life and emotional well-being for patients and their families.
The findings suggest the need for policy reforms and enhanced communication strategies to align treatment decisions more closely with patients’ wishes and quality of life goals. MD Anderson has made strides in reducing chemotherapy overutilization by promoting conversations about prognosis and end-of-life preferences, which is vital for providing compassionate, patient-centered care. Overall, this research underscores the importance of considering less aggressive, more supportive options in end-of-life cancer care.
Source: https://medicalxpress.com/news/2025-09-patients-anti-cancer-treatment-life.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Innovative Beta Cell Replacement Therapy Shows Promise for Type 1 Diabetes Cure
A novel stem cell–derived islet therapy, zimislecel, shows promise in restoring insulin production and eliminating severe hypoglycemia in adults with type 1 diabetes, offering new hope for a scalable cure.
New Research Uncovers How Kidneys Maintain Functional Balance Between Left and Right
A new study from the University of Tsukuba reveals the molecular mechanisms behind how the left and right kidneys maintain functional balance, emphasizing the role of angiotensin II in renal counterbalance and disease progression.
New Research Reveals Basal Stem-like Cells as the Origin of Small Cell Lung Cancer
A new study identifies basal stem-like cells as the origin of small cell lung cancer, highlighting new avenues for prevention and targeted treatment strategies.